Pharmafile Logo

Peter Impey

- PMLiVE

EFPIA’s Richard Torbett to move to the ABPI

Will take up commercial role at UK pharma bodyat the end of the month

Novartis building

US ruling clears Novartis’ Zarxio but could delay other biosimilars

Federalcourt's complex ruling could have a wide-ranging impact

- PMLiVE

NICE backs Bayer’s Eylea in diabetic eye condition

TheInstitute also recommends Allergan's Ozurdex in final guidance

- PMLiVE

Amgen beats Sanofi to PCSK9 inhibitor market

EC approval for Repatha gives it a lead over Praluent

- PMLiVE

Dr June Raine continues as chair of EMA’s pharmacovigilance committee

The PRAC also voted to extend Dr Almath Spooner's tenure asvice-chair

- PMLiVE

Creating stability with medicines framework

The deals secure stability for both industry and governments

Exploring full potential of e-detailing data

Today’s high quality e-detailing data can create better quality conversations with healthcare professionals and result in improved access and relationships.

Anthill Agency

Novartis day

Novartis sales dip, but all eyes are on Entresto

Newheart failure drug could return the company to growth

Bristol-Myers Squibb (BMS) building

Opdivo gets EU lung cancer nod as kidney cancer trial is halted

Bristol-MyersSquibb's checkpoint inhibitor gains European license for lung cancer

EISAI

Eisai to transfer US manufacturing campus to Biogen

Willhand over Research Triangle Park facility incapacity-sharing deal

- PMLiVE

Sonia Ruiz Moran appointed president of EMVO

She joins the verification organisation from the General Pharmaceutical Council of Spain

- PMLiVE

Sharing knowledge to combat emerging threats

'One health' advocates say closer cooperation between human and animal medicine firms could offer new solution

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links